Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study-Reference-Cited by-同舟云学术

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study

Published:2020-10-03 Issue:2 Volume:1 Page:498-506
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Nakayama Takafumi¹,Oshima Yoshiko²,Kusumoto Shigeru²,Yamamoto Junki¹,Osaga Satoshi³,Fujinami Haruna²,Kikuchi Takaki²,Suzuki Tomotaka²,Totani Haruhito²,Kinoshita Shiori²,Narita Tomoko²,Ito Asahi²,Ri Masaki²,Komatsu Hirokazu²,Wakami Kazuaki¹,Goto Toshihiko¹,Sugiura Tomonori¹,Seo Yoshihiro¹,Ohte Nobuyuki¹,Iida Shinsuke²

Affiliation:

1. Department of Cardiology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

2. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

3. Clinical Research Management Center Nagoya City University Hospital Nagoya Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.110

Reference39 articles.

1. Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association

2. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity

3. Doxorubicin-Induced Cardiac Toxicity

4. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.

5. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study;Cancer Medicine;2023-05-18

2. Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma;Circulation Reports;2022-04-08